alpha-L-Fucp-(1->3)-beta-D-Galp-(1->6)-beta-D-Galp

Term ID

CHEBI:147147

Synonyms

(2R,3R,4S,5R,6R)-6-[[(2R,3R,4S,5S,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2S,3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol
6-deoxy-alpha-L-galacto-hexopyranosyl-(1->3)-beta-D-galacto-hexopyranosyl-(1->6)-beta-D-galacto-hexopyranose
6-deoxy-alpha-L-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->6)-beta-D-galactopyranose
alpha-L-fucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->6)-beta-D-galactopyranose
Fuc(a1-3)Gal(b1-6)b-Gal
WURCS=2.0/2,3,2/[a2112h-1b_1-5][a1221m-1a_1-5]/1-1-2/a6-b1_b3-c1

(all 6)

Definition

A trisaccharide consisting of alpha-L-fucopyranose and two beta-D-galactopyranose residues joined in sequence by (1->3) and (1->6) glycosidic bonds.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->3)-beta-D-Galp-(1->6)-beta-D-Galp

Phenotype where environments contain alpha-L-Fucp-(1->3)-beta-D-Galp-(1->6)-beta-D-Galp

Phenotype modified by environments containing alpha-L-Fucp-(1->3)-beta-D-Galp-(1->6)-beta-D-Galp

Phenotype affecting alpha-L-Fucp-(1->3)-beta-D-Galp-(1->6)-beta-D-Galp

Human Disease Model